In the daily operations of PIVAS, a multitude of risks has been identified in the process of non-integral-dosage drugs. Therefore, we formed a project team. Employing the failure mode and effect analysis (FMEA) management method, we identified potential risks in four critical steps of the non-integral-dosage drug dispensing process within PIVAS drug management: prescription verification, mixed allocation, and verification. For each step, we assigned scores for severity, incidence, and detectability, subsequently calculating the Risk Priority Number (RPN) to prioritize identified risks. Targeted measures for improvement were developed for steps with the highest RPN values. Through the application of failure mode and effect analysis, we systematically managed the risks associated with non-integral-dosage drugs in PIVAS. This approach addressed safety concerns in the dispensing process, reduced errors, and ensured the safe and precise administration of medication to patients.
Geng, K.K. et al. / J. Chin. Pharm. Sci. 2024, 33 (7), 597–608.
>
>